| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/06/2008 | US20080058271 Dtection of autoantigen; diagnosis, therapy of autoimmune disease |
| 03/06/2008 | US20080058258 Growth Factor |
| 03/06/2008 | US20080058256 Metalloproteinase polypeptide; in vivo lysis of blood clots; genetic engineering; gene expression |
| 03/06/2008 | US20080057504 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders |
| 03/06/2008 | US20080057492 Interacting site for gp41 on gp120 of hiv-1 |
| 03/06/2008 | US20080057128 Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from |
| 03/06/2008 | US20080057113 virion vaccine anti-herpes simplex viruses containing hi-tech immunomodulator Polyoxidonium ( copolymer of 1,4-ethylene-piperazine N-oxide and (N-carboxyethyl)-1,4-ethylene-piperasinium bromide), valine, lysine together with metabolic amino acids; immunocompetent |
| 03/06/2008 | US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 03/06/2008 | US20080057085 Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax |
| 03/06/2008 | US20080057084 Selecting a patient determined to be responsive to administration of a botulinum neurotoxin for treatment of a headache by determining that the patient has or has a propensity to have an imploding headache pain, and administering a botulinum toxin to the selected patient, thereby treating the headache |
| 03/06/2008 | US20080057083 Protecting an animal against a pathogen by administering protective agent which is able to stimulate the animal's immune system to produce a response which is protective against the pathogen, and an immunostimulant comprising a polycationic carbohydrate or derivative thereof; non-parenteral immunization |
| 03/06/2008 | US20080057082 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 03/06/2008 | US20080057081 Influenza Hemagglutinin And Neuraminidase Variants |
| 03/06/2008 | US20080057080 Polynucleotide comprising a first nucleic acid fragment which encodes at least 20 contiguous amino acids of an influenza virus polypeptide, wherein codons of nucleic acid fragment are optimized for expression in humans; enhancing immune response of vertebrate in need of protection against IV infection |
| 03/06/2008 | US20080057079 JC Virus Vaccine |
| 03/06/2008 | US20080057078 Chicken Anemia Virus Vaccine from Cell Line |
| 03/06/2008 | US20080057077 Tumour-associated peptides binding to mhc-molecules |
| 03/06/2008 | US20080057076 Novel fibroblast growth factors |
| 03/06/2008 | US20080057075 Administering an antibody derivable from normal subject or from autoimmune disease subject that binds to lipid on surface of HIV or on surface of HIV-infected cells and thereby neutralizes HIV-1; invention provides immunogens that present MPER epitopes in their native membrane bound environment |
| 03/06/2008 | US20080057074 Nitrogenous Heterocylic Derivative and Medicine Containing the Same as an Active Ingredient |
| 03/06/2008 | US20080057073 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 03/06/2008 | US20080057072 Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders |
| 03/06/2008 | US20080057071 Use Of Hedgehog Pathway Inhibitors In Small-Cell Lung Cancer |
| 03/06/2008 | US20080057070 Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use |
| 03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 03/06/2008 | US20080057068 SARMS and method of use thereof |
| 03/06/2008 | US20080057067 Immunogenic polypeptide fragments and vaccines; outer membrane proteins; prevention of infections including meningitis |
| 03/06/2008 | US20080057066 Methods and compositions for targeting relt |
| 03/06/2008 | US20080057065 Phep, an Amino Acid Permease of Staphylococcus Aureus |
| 03/06/2008 | US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms |
| 03/06/2008 | US20080057063 human monoclonal antibodies; diagnostics and treatment of diseases associated with the activity and/or overproduction of alpha V beta 6; cancer |
| 03/06/2008 | US20080057061 Targeting carbohydrates on cell or viral particle surfaces; HIV-1 infection; colon cancer, melanoma or lung cancer |
| 03/06/2008 | US20080057060 Method and system to remove cytokine inhibitor in patients |
| 03/06/2008 | US20080057059 Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein S Inhibitors |
| 03/06/2008 | US20080057058 Uses of il-23 agonists and antagonists; related reagents |
| 03/06/2008 | US20080057057 Anti-Lipid Rafts Antibodies |
| 03/06/2008 | US20080057056 Fc Variants with Increased Affinity for FcyRIIC |
| 03/06/2008 | US20080057055 Human polynucleotide phosphorylase (hPNPaseold-35 or OLD-35); arthritis, atherosclerosis and Alzheimer's disease |
| 03/06/2008 | US20080057054 Controlling activity of telencephalin |
| 03/06/2008 | US20080057053 Bispecific antibodies and agents to enhance stem cell homing |
| 03/06/2008 | US20080057037 Treatment of neoplasms with viruses |
| 03/06/2008 | US20080057035 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 03/06/2008 | US20080057029 Administering cell expressing a cytokine from a recombinant polynucleotide, where the cells has been inactivated to prevent proliferation; a mixture of antigen and genetic engineered allogenic cell |
| 03/06/2008 | US20080057006 genetic vaccines comprising a recombination activating gene (rag) nucleotide sequence, used to code polypeptides, for the prevention and/or treatment of periodontal diseases, caused by infection by Porphyromonas gingivalis |
| 03/06/2008 | US20080056997 preferential binding members against extracellular matrix proteins, especially scFv antibody molecules against peptide domains of the glycoprostien, conjugated with labels, cytotoxic molecules or cytokines, for use in diagnosis and treatment of cancer |
| 03/06/2008 | CA2662174A1 Vaccines and methods for treatment or prevention of salmonella spp. bacterial infection in a vertebrate subject |
| 03/06/2008 | CA2662164A1 Method of eliciting or inducing an immune response |
| 03/06/2008 | CA2661803A1 Antibodies, assays and hybridomas |
| 03/06/2008 | CA2661782A1 Antagonistic human light-specific human monoclonal antibodies |
| 03/06/2008 | CA2660804A1 Reverse targeting lipid vesicle |
| 03/06/2008 | CA2660175A1 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 03/05/2008 | EP1895017A2 Use of A33 antigens and JAM-IT |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1894941A1 Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens |
| 03/05/2008 | EP1894012A2 Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling |
| 03/05/2008 | EP1893752A2 Attenuated sars and use as a vaccine |
| 03/05/2008 | EP1893650A2 Hiv tat-cd4 hybried molecules and methods of use thereof |
| 03/05/2008 | EP1893649A2 Method for the potentiation of opioid analgesics effects on pain |
| 03/05/2008 | EP1893645A1 Optimization of west nile virus antibodies |
| 03/05/2008 | EP1893640A2 Composition comprising fractions or sub-fractions of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmani |
| 03/05/2008 | EP1893636A2 Hepatitis c virus nucleic acid vaccine |
| 03/05/2008 | EP1893234A2 MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT |
| 03/05/2008 | EP1893233A2 Therapeutic peptides and vaccines |
| 03/05/2008 | EP1893232A2 New adjuvant |
| 03/05/2008 | EP1893223A1 Highly attenuated pox virus strains, method for the production thereof and the use thereof as paramunity inducers or for producing vector vaccines |
| 03/05/2008 | EP1292289B1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 03/05/2008 | EP1282710B1 Fish vaccine against piscirickettsia salmonis |
| 03/05/2008 | EP1238985B1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 03/05/2008 | EP1233969B1 Mono- and disaccharide derivatives |
| 03/05/2008 | EP1207904B1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 03/05/2008 | EP1030862B1 Viral clearance process |
| 03/05/2008 | EP1007720B1 Dendritic cell hybrids |
| 03/05/2008 | EP0960337B1 Cathepsin K and breast cancer |
| 03/05/2008 | EP0690912B1 Recombinant avian adenovirus vector |
| 03/05/2008 | CN101137748A Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 03/05/2008 | CN101137673A Cripto结合分子 Cripto binding molecules |
| 03/05/2008 | CN101137671A Anti-igsf4 antibody and utilization of the same |
| 03/05/2008 | CN101137664A Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
| 03/05/2008 | CN101137394A Anti-addl antibodies and uses thereof |
| 03/05/2008 | CN101137393A Improved vaccine against feline calicivirus |
| 03/05/2008 | CN101137392A Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 03/05/2008 | CN101137390A Novel angiogensis inhibitor |
| 03/05/2008 | CN101134781A Recombinant fusion protein carrying anthrax protective antigens epitope inserted to hepatitis B core antigen protein or its fragment and uses thereof |
| 03/05/2008 | CN101134779A Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/05/2008 | CN101134778A Monoclonal antibody of esophagus cancer resistant blood vessel endothelium cell |
| 03/05/2008 | CN101134777A Method for preparing humanized immune globulin capable of antagonizing vessel endothelium cell growth factor and combined uses thereof |
| 03/05/2008 | CN101134775A Novel streptococcus antigens |
| 03/05/2008 | CN101134772A Method for separating membrane protein of sucking sperm rear head and uses thereof |
| 03/05/2008 | CN101134107A Antithrombotic agents |
| 03/05/2008 | CN101134102A 5T4 tumour-expressed antigen |
| 03/05/2008 | CN101134101A 5T4 tumour-associated antigen |
| 03/05/2008 | CN101134016A Recombination human body CD25-resist inosculated monoclone antibody liquid injection and method of manufacturing the same |
| 03/05/2008 | CN100372944C The use of PDE4D in the screening for medicaments against atherosclerosis |
| 03/05/2008 | CN100372936C I (vibrio cholerae) vaccine candidates and method of their constructing |
| 03/05/2008 | CN100372566C Targeted delivery of drugs for treatment of viral infections |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339043 Compositions and methods for affecting virulence determinants in bacteria |
| 03/04/2008 | US7339042 cytotoxic fusion proteins that are useful for selectively killing endothelial cells in blood vessels that feed tumors |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7339037 nucleoside sequence polypeptides; therapy, prevention of influenza viral infections |